»

27 November 2009 3:35 PM ( 113 days ago)
* Gets complete response letter on Telavancin for pneumonia * FDA asks for additional data * Co says already collected data asked by FDA Nov 27 - Drug developer Theravance Inc said U.S. health regulators did not approve its drug Telavancin for treatment of nosocomial pneumonia. The ...
astellas pharma inc
To comment or read log in. No account? Register free.




 submit 'FDA denies approval for Theravances pneumonia drug' on facebook   submit 'FDA denies approval for Theravances pneumonia drug' to digg   submit 'FDA denies approval for Theravances pneumonia drug' to Stumbleupon
No one has commented on this article yet.